{"id":"https://openalex.org/W4410141779","doi":"https://doi.org/10.1056/nejmc2503524","title":"Cabozantinib in Advanced Neuroendocrine Tumors","display_name":"Cabozantinib in Advanced Neuroendocrine Tumors","publication_year":2025,"publication_date":"2025-05-07","ids":{"openalex":"https://openalex.org/W4410141779","doi":"https://doi.org/10.1056/nejmc2503524","pmid":"https://pubmed.ncbi.nlm.nih.gov/40334169"},"language":"en","primary_location":{"id":"doi:10.1056/nejmc2503524","doi":"https://doi.org/10.1056/nejmc2503524","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmc2503524","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},"volume":null,"type":"letter","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jennifer A Chan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer A Chan","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007148032","display_name":"Susan Michelle Geyer","orcid":"https://orcid.org/0009-0002-5649-6909","observed_orcids":["https://orcid.org/0009-0002-5649-6909"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan Geyer","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027170448","display_name":"Jeffrey A. Meyerhardt","orcid":"https://orcid.org/0000-0002-1120-0898","observed_orcids":["https://orcid.org/0000-0002-1120-0898"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey A Meyerhardt","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"392","issue":"18","first_page":"1869","last_page":"1870"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cabozantinib","display_name":"cabozantinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/pancreatic-neuroendocrine-tumors","display_name":"pancreatic neuroendocrine tumors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9800000190734863},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9909999966621399},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.6119999885559082},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.7580000162124634},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4009999930858612}],"concepts":[{"id":"https://openalex.org/C2781064419","wikidata":"https://www.wikidata.org/wiki/Q795057","display_name":"Cabozantinib","level":3,"score":0.9638828635215759},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.6942957639694214},{"id":"https://openalex.org/C3020482125","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine carcinoma","level":3,"score":0.44422969222068787},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.440457284450531},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4038558900356293},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3790968656539917},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.10330632328987122},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.10084176063537598}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1056/nejmc2503524","doi":"https://doi.org/10.1056/nejmc2503524","is_oa":false,"landing_page_url":"https://doi.org/10.1056/nejmc2503524","pdf_url":null,"source":{"id":"https://openalex.org/S62468778","display_name":"New England Journal of Medicine","issn_l":"0028-4793","issn":["0028-4793","0096-6762","1533-4406","2331-4710"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320239","host_organization_name":"Massachusetts Medical Society","host_organization_lineage":["https://openalex.org/P4310320239"],"host_organization_lineage_names":["Massachusetts Medical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"New England Journal of Medicine","raw_type":"journal-article"},{"id":"pmid:40334169","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40334169","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Letter"},{"id":"pmid:40334170","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40334170","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The New England journal of medicine","raw_type":"Letter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W3187533975","https://openalex.org/W3217485783","https://openalex.org/W4200415204","https://openalex.org/W4400597727","https://openalex.org/W4402350965","https://openalex.org/W4402581225"],"related_works":["https://openalex.org/W4402581225","https://openalex.org/W7122782077","https://openalex.org/W4406868771","https://openalex.org/W4402560687","https://openalex.org/W4402770140","https://openalex.org/W7162658458","https://openalex.org/W4415942747","https://openalex.org/W4416726445","https://openalex.org/W4413795099","https://openalex.org/W4402582293"],"abstract_inverted_index":{"To":[0],"the":[1,11,14],"Editor:":[2],"Chan":[3],"et":[4],"al.":[5],"(Feb.":[6],"13":[7],"issue)":[8],"1":[9],"report":[10],"results":[12],"of":[13,77],"phase":[15],"3":[16],"CABINET":[17],"(Cabozantinib":[18],"versus":[19],"Placebo":[20],"in":[21,56,64,75],"Patients":[22],"with":[23,36,44],"Advanced":[24],"Neuroendocrine":[25],"Tumors":[26],"after":[27],"Progression":[28],"on":[29],"Prior":[30],"Therapy)":[31],"trial.":[32],"Cabozantinib,":[33],"as":[34],"compared":[35],"placebo,":[37],"significantly":[38],"improved":[39],"progression-free":[40,57,78],"survival":[41,58],"among":[42,93],"patients":[43,73,82,95],"previously":[45],"treated,":[46],"progressive":[47],"pancreatic":[48],"or":[49,91],"extrapancreatic":[50],"neuroendocrine":[51],"tumors.":[52],"Nevertheless,":[53],"this":[54],"improvement":[55,63],"did":[59,83],"not":[60],"translate":[61],"to":[62],"overall":[65],"survival.":[66],"Subgroup":[67],"analyses":[68],"showed":[69],"that":[70],"only":[71],"White":[72],"benefited":[74],"terms":[76],"survival,":[79],"whereas":[80],"non-White":[81,94],"not.":[84],"The":[85],"hazard":[86],"ratio":[87],"for":[88],"disease":[89],"progression":[90],"death":[92],"was":[96],"0.59":[97],"(95%":[98],"confidence":[99],"interval":[100],".":[101,102,103]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2025-05-07T00:00:00"}